Literature DB >> 27139059

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

Katherine E Fleming-Dutra1, Adam L Hersh2, Daniel J Shapiro3, Monina Bartoces1, Eva A Enns4, Thomas M File5, Jonathan A Finkelstein6, Jeffrey S Gerber7, David Y Hyun8, Jeffrey A Linder9, Ruth Lynfield10, David J Margolis11, Larissa S May12, Daniel Merenstein13, Joshua P Metlay14, Jason G Newland15, Jay F Piccirillo16, Rebecca M Roberts1, Guillermo V Sanchez1, Katie J Suda17, Ann Thomas18, Teri Moser Woo19, Rachel M Zetts8, Lauri A Hicks1.   

Abstract

IMPORTANCE: The National Action Plan for Combating Antibiotic-Resistant Bacteria set a goal of reducing inappropriate outpatient antibiotic use by 50% by 2020, but the extent of inappropriate outpatient antibiotic use is unknown.
OBJECTIVE: To estimate the rates of outpatient oral antibiotic prescribing by age and diagnosis, and the estimated portions of antibiotic use that may be inappropriate in adults and children in the United States. DESIGN, SETTING, AND PARTICIPANTS: Using the 2010-2011 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, annual numbers and population-adjusted rates with 95% confidence intervals of ambulatory visits with oral antibiotic prescriptions by age, region, and diagnosis in the United States were estimated. EXPOSURES: Ambulatory care visits. MAIN OUTCOMES AND MEASURES: Based on national guidelines and regional variation in prescribing, diagnosis-specific prevalence and rates of total and appropriate antibiotic prescriptions were determined. These rates were combined to calculate an estimate of the appropriate annual rate of antibiotic prescriptions per 1000 population.
RESULTS: Of the 184,032 sampled visits, 12.6% of visits (95% CI, 12.0%-13.3%) resulted in antibiotic prescriptions. Sinusitis was the single diagnosis associated with the most antibiotic prescriptions per 1000 population (56 antibiotic prescriptions [95% CI, 48-64]), followed by suppurative otitis media (47 antibiotic prescriptions [95% CI, 41-54]), and pharyngitis (43 antibiotic prescriptions [95% CI, 38-49]). Collectively, acute respiratory conditions per 1000 population led to 221 antibiotic prescriptions (95% CI, 198-245) annually, but only 111 antibiotic prescriptions were estimated to be appropriate for these conditions. Per 1000 population, among all conditions and ages combined in 2010-2011, an estimated 506 antibiotic prescriptions (95% CI, 458-554) were written annually, and, of these, 353 antibiotic prescriptions were estimated to be appropriate antibiotic prescriptions. CONCLUSIONS AND RELEVANCE: In the United States in 2010-2011, there was an estimated annual antibiotic prescription rate per 1000 population of 506, but only an estimated 353 antibiotic prescriptions were likely appropriate, supporting the need for establishing a goal for outpatient antibiotic stewardship.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27139059     DOI: 10.1001/jama.2016.4151

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  436 in total

1.  Reductions in Parent Interest in Receiving Antibiotics following a 90-Second Video Intervention in Outpatient Pediatric Clinics.

Authors:  Kathy Goggin; Emily A Hurley; Andrea Bradley-Ewing; Carey Bickford; Brian R Lee; Kimberly Pina; Evelyn Donis De Miranda; Alexander Mackenzie; David Yu; Kirsten Weltmer; Sebastian Linnemayr; Christopher C Butler; Melissa Miller; Jason G Newland; Angela L Myers
Journal:  J Pediatr       Date:  2020-06-15       Impact factor: 4.406

2.  Categorical Risk Perception Drives Variability in Antibiotic Prescribing in the Emergency Department: A Mixed Methods Observational Study.

Authors:  Eili Y Klein; Elena M Martinez; Larissa May; Mustapha Saheed; Valerie Reyna; David A Broniatowski
Journal:  J Gen Intern Med       Date:  2017-06-20       Impact factor: 5.128

3.  Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease.

Authors:  Stacy Aric Johnson; Austin Bernard Rupp; Kirsten Leigh Rupp; Santosh Reddy
Journal:  Intern Emerg Med       Date:  2021-01-16       Impact factor: 3.397

4.  Antibiotic Prescriptions Associated With Dental-Related Emergency Department Visits.

Authors:  Rebecca M Roberts; Adam L Hersh; Daniel J Shapiro; Katherine E Fleming-Dutra; Lauri A Hicks
Journal:  Ann Emerg Med       Date:  2018-11-02       Impact factor: 5.721

5.  Cumulative Probability of Receiving an Antibiotic Prescription over Time.

Authors:  Scott W Olesen; Derek MacFadden; Yonatan H Grad
Journal:  N Engl J Med       Date:  2019-05-09       Impact factor: 91.245

6.  Antibiotic Prescribing for Children in United States Emergency Departments: 2009-2014.

Authors:  Nicole M Poole; Daniel J Shapiro; Katherine E Fleming-Dutra; Lauri A Hicks; Adam L Hersh; Matthew P Kronman
Journal:  Pediatrics       Date:  2019-01-08       Impact factor: 7.124

7.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

Review 8.  Functional Nitric Oxide Nutrition to Combat Cardiovascular Disease.

Authors:  Nathan S Bryan
Journal:  Curr Atheroscler Rep       Date:  2018-03-17       Impact factor: 5.113

9.  Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Authors:  Alice Y Guh; Yi Mu; Lisa G Winston; Helen Johnston; Danyel Olson; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Ghinwa K Dumyati; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

10.  Procalcitonin Correlates With but Is Not Superior to Other Diagnostic Markers of Bacterial Pneumonia.

Authors:  Nadia Ayala-Lopez; David R Peaper; Roa Harb
Journal:  Am J Clin Pathol       Date:  2021-03-15       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.